VCYT
Veracyte, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers):
breedte van houders -6.2% ·
aandelenstroom -12.5% ·
netto nieuwe posities -6.7%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 119 | +4 | 67.58M | $3.96B | +10 | −6 |
| Q1 2026 | 118 | +6 | 67.37M | $2.17B | +10 | −4 |
| Q4 2025 | 112 | 0 | 69.04M | $2.91B | +2 | −2 |
| Q3 2025 | 18 | -2 | 46.98M | $1.61B | — | −3 |
| Q2 2025 | 18 | 0 | 39.06M | $1.06B | +1 | −1 |
| Q1 2025 | 15 | -1 | 15.53M | $460.45M | — | −1 |
| Q4 2024 | 16 | +1 | 17.75M | $702.81M | +1 | — |
| Q3 2024 | 14 | +1 | 14.22M | $484.20M | +3 | −2 |
| Q2 2024 | 13 | — | 18.04M | $390.85M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 3.94M | -6.3% | $116.80M | 1.2% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 3.85M | -5.7% | $114.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.85M | -5.7% | $114.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.85M | -5.7% | $114.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.85M | -5.7% | $114.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.85M | -5.7% | $114.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.85M | -5.7% | $114.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (passief) | 3.16M | +8.5% | $93.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passief) | 1.93M | +5.2% | $57.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 1.93M | +5.2% | $57.38M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 848.61K | +0.3% | $25.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 832.00K | +38.5% | $24.67M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 490.85K | -22.7% | $14.55M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 195.89K | -14.9% | $5.81M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 195.89K | -14.9% | $5.81M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 195.89K | -14.9% | $5.81M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 195.89K | -14.9% | $5.81M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 195.89K | -14.9% | $5.81M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Norges Bank ✦ (passief) | 100.50K | -55.5% | $2.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 57.80K | +19.4% | $1.71M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 56.77K | -80.8% | $1.68M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Point72 Asset Management ✦ | 25.16K | -95.2% | $745,964 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 18.88K | -5.9% | $559,822 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Millennium Management ✦ | 8.87K | -96.3% | $262,966 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Marshall Wace ✦ | 8.33K | -99.1% | $247,014 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| D. E. Shaw & Co. | $3.41M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 333 houders, 87.61M aandelen, $2.75B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.